Table 3. Immune-mediated adverse events during consolidation therapy.
| Adverse event | Total n (%) | Grade 1 n (%) | Grade 2 n (%) | Grade 3 n (%) |
|---|---|---|---|---|
| Pneumonitis | 4 (12.9) | 1 (3.2) | 2 (6.4) | 1 (3.2) |
| Hypothyroidism | 3 (9.7) | 1 (3.2) | 2 (6.4) | 0 (0.0) |
| Pruritus | 1 (3.2) | 1 (3.2) | 0 (0.0) | 0 (0.0) |
The percentages presented in this Table were calculated using the total number of patients (N=31) as the denominator.